Total Valuation
Impedimed Limited has a market cap or net worth of $13.12M. The enterprise value is $12.52.
Market Cap$13.12M
Enterprise Value$12.52
Share Statistics
Impedimed Limited has 3,662,493,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,662,493,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Impedimed Limited’s return on equity (ROE) is -2.44 and return on invested capital (ROIC) is -73.32%.
Return on Equity (ROE)-2.44
Return on Assets (ROA)-0.72
Return on Invested Capital (ROIC)-73.32%
Return on Capital Employed (ROCE)-0.78
Revenue Per Employee189.78K
Profits Per Employee-323.47K
Employee Count77
Asset Turnover0.42
Inventory Turnover11.99
Valuation Ratios
The current PE Ratio of Impedimed Limited is ―. Impedimed Limited’s PEG ratio is -0.25.
PE Ratio―
PS Ratio0.73
PB Ratio1.05
Price to Fair Value1.05
Price to FCF-0.53
Price to Operating Cash Flow-0.56
PEG Ratio-0.25
Income Statement
In the last 12 months, Impedimed Limited had revenue of 14.61M and earned -24.91M in profits. Earnings per share was -0.01.
Revenue14.61M
Gross Profit-11.89M
Operating Income-22.11M
Pretax Income-26.09M
Net Income-24.91M
EBITDA-22.11M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -20.03M and capital expenditures 20.03M, giving a free cash flow of 0.00 billion.
Operating Cash Flow-20.03M
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Impedimed Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.06
52-Week Price Change-50.00%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)14.88
Average Volume (3m)5.35K
Important Dates
Impedimed Limited upcoming earnings date is Oct 29, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateOct 29, 2026
Ex-Dividend Date―
Financial Position
Impedimed Limited as a current ratio of 3.81, with Debt / Equity ratio of 5.00%
Current Ratio3.81
Quick Ratio3.45
Debt to Market Cap0.03
Net Debt to EBITDA0.67
Interest Coverage Ratio-5.93
Taxes
In the past 12 months, Impedimed Limited has paid -1.18M in taxes.
Income Tax-1.18M
Effective Tax Rate0.05
Enterprise Valuation
Impedimed Limited EV to EBITDA ratio is 0.19, with an EV/FCF ratio of 0.20.
EV to Sales-0.28
EV to EBITDA0.19
EV to Free Cash Flow0.20
EV to Operating Cash Flow0.20
Balance Sheet
Impedimed Limited has $15.29M in cash and marketable securities with $509.00K in debt, giving a net cash position of $14.78M billion.
Cash & Marketable Securities$15.29M
Total Debt$509.00K
Net Cash$14.78M
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is -81.36%, with operating margin of -151.27%, and net profit margin of -170.44%.
Gross Margin-81.36%
Operating Margin-151.27%
Pretax Margin-178.54%
Net Profit Margin-170.44%
EBITDA Margin-151.27%
EBIT Margin-151.27%
Analyst Forecast
The average price target for Impedimed Limited is <$0.01, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target<$0.01
Price Target Upside-28.03% Downside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast20.40%
EPS Growth Forecast-6.76%